The current research focus of the drug is to evaluate the efficacy of the drug in patients with severe autoimmune diseases.

Fresenius SE & Co. KGaA is a pharmaceutical organization that was founded in 1912 and is based in Hessen, Germany.

Exosomes, a subpopulation of EVs, are small vesicles produced naturally by cells that play a role in intercellular communication.

Les Laboratoires Servier SAS is a pharmaceutical organization based in France that was founded in 1954.

Shanghai Pharmaceuticals Holding Co., Ltd. is a pharmaceutical organization based in Shanghai, China. It was founded in 1994 and has since become a prominent player in the biomedicine industry.

Vorolanib is a new generation of multi target kinase inhibitors with a completely new chemical structure.

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company that was founded in 1992 and is headquartered in Connecticut, United States.

CSPC Pharmaceutical Group Ltd. is a pharmaceutical organization based in Hong Kong SAR, China. It was founded in 1997 and has since become a prominent player in the biomedicine industry.

The potential use of mannose as a supplement to inhibit gasdermin-mediated pyroptosis by activating AMPK, as described in the study published on Cell Research, presents a novel and promising avenue for the development of cancer treatments, offering a promising approach to mitigating the harsh side effects of chemotherapy.

Ipsen SA is a pharmaceutical organization that was founded in 1929 and is based in France.

Aurobindo Pharma Ltd. is a pharmaceutical organization that was founded in 1986 and is based in Andhra Pradesh, India.

YTH domain-containing family protein 1 (YTHDF1) is a translation-promoting m6A reader that targets mRNAs in the cytoplasm and contributes to tumor progression by regulating cell proliferation, DNA damage, and immunity.